BIOTON S.A.’s Post

Today we are proud to present Edyta Wysocka, our Head of Biotechnology Plant. In our latest #MeetBIOTON interview we asked Edyta a few questions about her work and passions, as well what drives her the most in life. Check out whole article on our website: PL: https://lnkd.in/dsrfEy8m ENG: https://lnkd.in/djju8QZt But the last question is for you – who should we interview next? Tell us in comments below ⬇ #MeetBIOTON #OurTeam #TeamWork

We are very proud to annouce that our Logistics Coordinator, Łukasz Marczak was featured in prestigious „World of Pharmaceutical Industry”. In his article titled „Transport of Insulin in the Cold Chain” Łukasz delved into the critical processes involved in ensuring that insulin reaches patient in perfect conditions. Insulin needs to be transported in consistent temperature, from +2°C to +8°C – to achieve this, special precautions are needed, like refrigerated containers and temperature-controlled packaging. Compliance with Good Distribution Practice (GDP) is also crucial Thank you Łukasz and congratulation for this achievement! #proud #coldchain #healthcareinnovation

At Bioton, we appreciate and celebrate every success of our employees. Radosław Gładysz, our Development Specialist in the Science and Technology Department, has just defended his PhD at the Wroclaw University of Science and Technology.🎉 His dissertation "Study of the extended specificity profile of human proteasomes," is a reflection of his commitment and passion. Congratulations, Radek! Your achievements are a source of pride for us! 👏🎓 #TeamBuilding #BiotonTeam #work #experiences

Drug safety has become an extremely important topic following the experiences of the COVID-19 pandemic. Currently, in the face of the ongoing war in Ukraine, ensuring the stability of drug supplies is as crucial as military security, due to the fact that most of API is imported from the East - it is not produced in Europe - what can be done to secure patients with lifesaving drugs? This was the subject of discussion during the panel at last week's II Polish-German Economic Forum.   Our Manufacturing Scientific and Technology Director, Dariusz Gurtowski, participated in the panel alongside Sebastian Szymanek, CEO of Polpharma, Anna Krzyżanowska, Head of Governmental Affairs and Market Access at Merck, and Przemek Grzywa, Cofounder of Revolve Healthcare. They all tackled the question: Does Poland have the potential to become a pharmaceutical logistics and production hub? From our perspective – absolutely! As one of the largest biotechnology companies in Europe - producer of API and Drug Products, we are already producing in Poland Recombinant Human Insulin and have the capability to produce recombinant protein but also to adopt new technologies through technology transfer, in accordance with cGMP requirements, produce #BioTech API and do the formulation, as a sterile liquid forms dosed into vials and cartridges. Drug safety procedures ensure the availability of drugs and key Active Pharmaceutical Ingredients (API). This implementation of production technology in Poland, where factories, production capacity and experience in the production of life-saving drugs are already available, will ensure drug safety - patient safety. #biotechnology #drugsafety #logistics

We have exiting news to share from 84th Scientific Sessions of the American Diabetes Association! Two posters, based on studies performed at Polish clinical centres with recombinant human insulin produced at Bioton and Intesta Max, were presented at Sessions. Effectiveness and safety of human insulin treatment In elderly patients with type 2 diabetes. Effect of butyrate on GI signs, SIBO, and Diabetes Control – randomized. Placebo-controlled Study in patients with type 2 diabetes. Big congratulations to Prof. Grzegorz Dzida and Prof. Edward Frank for your work!   This is tremendous success - but none of this would be possible without the huge effort and commitment of all people involved in conducting the research as well as the preparation of the publications based on the results obtained. Thank you. #diabetes #ada #success

Today we had a pleasure to officially celebrate completion of our new project – solar panel installation. There’s no better time than sunny summer to complete this kind of project. This investment is another milestone in the list of our eco-friendly practices. Reducing carbon dioxide emissions was our goal for a long time and we’re incredibly happy that this installation will let us work a little closer in harmony with climate. The total power of our installation is approximately 1.8 MW – which covers part of our annual electricity demand. We would like to thank the whole team responsible for the project: Klaudia Wyszyńska, Ryszard Szweda, Anna Podniesińska, Mariusz Nasiadka, Jarosław Grabowski, led by Jolanta Lis & Michał Deptuch, as well as other divisions working on it – you did great job and we’re very grateful for it! It is only beginning of our future plans :) #innovation #solarpower #ecofriendly

We love to share our knowledge and inspire others, especially those, who are just starting their scientific journey. So when we had a chance to accommodate visit from Department of Drug Technology and Pharmaceutical Biotechnology (Medical University of Warsaw), we couldn’t say no! Students had the opportunity to see our work from the very inside, experience more practical side of pharmaceutical technology, quality insurance, distribution and R&D, and meet our experts. We got only good reviews after this seminar – which we are very grateful for. We hope this will help students in pursuing career in our field! Thank you Medical University of Warsaw - MUW, our doors are always open for you! #biotechnology #students #seminar #university

We all know that the number of people with diabetes is increasing, but there are different faces of diabetes. The most common are type 1 diabetes and type 2 diabetes. Can you identify the differences between them? Here are some facts on the two types of diabetes 👇 #diabetesawareness #diabeteseducation #type1diabetes #type2diabetes

There's only one that important and that big conference on diabetology in Poland - Scientific Meeting of the Polish Diabetes Society. We couldn't miss an event of such significance! This year, which was 25th of this conference, we were honored to be bronze sponsor and for 3 days we had opportunity to learn the latest worldwide research in the diabetes treatment and technology but also meet, talk and - hopefully! – inspire other participants. Since at BIOTON we've been working for more than 23 years to manufacture recombinant human insulin from the biosynthesis of active substance to the final product and providing people with diabetes with high quality solutions - we had a lot to share. We are delighted that during the conference HCPs could hear the latest data of joint project of Biotts and BIOTON on the transdermal insulin. Dr. Paweł Biernat, Pharm.D., presented a lecture: "Alternative methods of delivering anti-diabetic agents using an innovative transdermal carrier”. We are proud to be part of the project aimed at providing patients with an innovative solution that can significantly improve their quality of life and make living with diabetes easier. We're very grateful for every inspiring event. Let's meet again next year! #PTD #biotechnology #diabetology #conference #networking